Immunologic Deficiency Syndromes: all 702 studies
Page 3 of 8. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.
- Drug Use Investigation of KaletraCompletedNCT01076972Results posted
- Kaletra in Combination With Antiretroviral AgentsCompletedNCT01076179Results posted
- Kaletra: Therapy With Double Protease InhibitorsCompletedNCT01075191Results posted
- Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant DisordersCompletedNCT01050855Phase 2Results posted
- Donor Lymphocyte Infusion After Alternative Donor TransplantationTerminatedNCT01027702Phase 1/2Results posted
- A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency DiseasesCompletedNCT01012323Phase 3Results posted
- Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.CompletedNCT00985543Phase 1Results posted
- T-cell Depleted Alternative Donor TransplantationTerminatedNCT00968864Phase 2Results posted
- Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMACCompletedNCT00923364Phase 2Results posted
- A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected ChildrenCompletedNCT00919854Phase 2Results posted
- A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected PatientsCompletedNCT00903682Phase 2Results posted
- TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV PatientsCompletedNCT00896051Phase 2Results posted
- A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected PatientsCompletedNCT00838162Phase 2Results posted
- Pilot Study of a Raltegravir Based NRTI Sparing RegimenCompletedNCT00814879Not applicableResults posted
- Gammagard Liquid and rHuPH20 in PIDCompletedNCT00814320Phase 3Results posted
- Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency DiseasesTerminatedNCT00811174Phase 3Results posted
- MND-ADA Transduction of CD34+ Cells From Children With ADA-SCIDCompletedNCT00794508Phase 2Results posted
- Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV DiseaseTerminatedNCT00775606Phase 4Results posted
- Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)CompletedNCT00751621Phase 3Results posted
- Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant DisordersCompletedNCT00744692Phase 1Results posted
- Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)CompletedNCT00719680Phase 3Results posted
- Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)CompletedNCT00711009Phase 3Results posted
- Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric SubjectsCompletedNCT00634569Phase 4Results posted
- ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCIDCompletedNCT00598481Phase 2Results posted
- Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency DisordersTerminatedNCT00579137Phase 1/2Results posted
- CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell DepletionCompletedNCT00579124Phase 2Results posted
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited DisordersCompletedNCT00553098Phase 2Results posted
- Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) SubjectsCompletedNCT00546871Phase 2/3Results posted
- Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement TherapyCompletedNCT00542997Phase 3Results posted
- Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)CompletedNCT00538915Phase 3Results posted
- Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) SyndromeTerminatedNCT00527878Phase 2Results posted
- A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)CompletedNCT00524368Phase 3Results posted
- Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary ImmunodeficiencyCompletedNCT00520494Phase 4Results posted
- Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1TerminatedNCT00490100Phase 1/2Results posted
- Multicenter, Safety Study Of MaravirocCompletedNCT00478231Phase 3Results posted
- Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/RitonavirCompletedNCT00458302Phase 3Results posted
- Donor Stem Cell Transplantation for Congenital ImmunodeficienciesCompletedNCT00426517Early Phase 1Results posted
- Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement TherapyCompletedNCT00419341Phase 3Results posted
- A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary ImmunodeficiencyCompletedNCT00389324Phase 2Results posted
- Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected SubjectsCompletedNCT00358917Phase 3Results posted
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited DisordersTerminatedNCT00358657Phase 2Results posted
- Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic SuppressionCompletedNCT00337467Phase 3Results posted
- ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial RegimensCompletedNCT00335322Phase 4Results posted
- Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)CompletedNCT00322556Phase 3Results posted
- Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.CompletedNCT00278954Phase 3Results posted
- Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected SubjectsCompletedNCT00262522Phase 3Results posted
- Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
- T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTerminatedNCT00176826Phase 2/3Results posted
- A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 StudyCompletedNCT00128830Phase 2Results posted
- A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral MedicinesCompletedNCT00110305Phase 2Results posted
- Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)CompletedNCT00105157Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)CompletedNCT00100048Phase 2Results posted
- Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) PatientsCompletedNCT00082628Phase 3Results posted
- Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)CompletedNCT00000134Phase 3Results posted
- CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary ImmunodeficiencyActive, not recruitingNCT07015801Not applicable
- Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected PeopleCompletedNCT06576024Phase 4
- At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa SkillCompletedNCT06150534
- The Sequestration of Holistic Stress Management Techniques for AdultsWithdrawnNCT06098755Not applicable
- Assessment of the Increased Risk of Infection Following an UltratrailCompletedNCT06089174Not applicable
- Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICFCompletedNCT06014463
- Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary ImmunodeficienciesStatus unknownNCT05986734
- Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South AfricaActive, not recruitingNCT05933226Not applicable
- Approaches and Metrics in Fraily Patients During COVID-19 EraCompletedNCT05792891
- MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)WithdrawnNCT05700734Phase 1
- Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico CityStatus unknownNCT05685641Not applicable
- Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised PatientsWithdrawnNCT05672654Not applicable
- Pediatric Intensive Care Unit and Primary Immune DeficiencyCompletedNCT05629247Not applicable
- HIV Education Kit for Adolescents (Pencegahan HIV di Kalangan Remaja), PREM-KitCompletedNCT05623800Not applicable
- Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving ChemotherapyStatus unknownNCT05605808Not applicable
- The Effect of Yoga for Stress Among HIV Patients in IndonesiaCompletedNCT05503680Not applicable
- Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Common ImmunodeficiencyStatus unknownNCT05481554
- A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) .Status unknownNCT05476653Not applicable
- Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of TuberculosisCompletedNCT05452616Not applicable
- Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody SyndromeCompletedNCT05354583
- COVID-19 Vaccine Responses in PIDD SubjectsActive, not recruitingNCT05321407
- High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients TrialCompletedNCT05306704Phase 3
- Mountain Food and Natural Probiotic in NutritionCompletedNCT05256784
- A Safety Study of Brentuximab Vedotin in Participants With HIVWithdrawnNCT05244473Phase 1
- HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
- A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected ChildrenCompletedNCT05197075Phase 1
- Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)WithdrawnNCT05115838Phase 2
- Active Hexose Correlated Compound in Tuberculosis-HIV (Human Immunodeficiency Virus) InfectionCompletedNCT05100758Not applicable
- An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)Status unknownNCT05070455Phase 4
- Nutrition, Immunity, and Covid-19 in Obese PeopleCompletedNCT04979065Phase 2
- Primary Immunodeficiencies in Costa Rican AdultsCompletedNCT04963660
- B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody DeficiencyCompletedNCT04954469Phase 1/2
- Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19Status unknownNCT04836260Phase 3
- Covid-19 Vaccine Cohort in Specific PopulationsCompletedNCT04824651
- Immunoglobulin G Therapy Dose OptimizationCompletedNCT04818177
- Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)CompletedNCT04799353Phase 1
- Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 VaccineCompletedNCT04798677Not applicable
- HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
- Immune and Scfa Profile of Stunting ChildrenCompletedNCT04698759
- The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid OrgansStatus unknownNCT04646525
- Assessing the Effects of CytoSorb Hemoperfusion on the Development on ImmunoparalysisCompletedNCT04643639Phase 3
- Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID)CompletedNCT04636502
- Community Based Screening for HIV Self Testing in FSW in 23 Priority Districts in IndonesiaStatus unknownNCT04578145Not applicable
- Rituximab and Abatacept Effectiveness in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.Status unknownNCT04572620
- Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)CompletedNCT04554966Phase 1
- A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesActive, not recruitingNCT04554914Phase 2